Clinical Research

The American Heart Association (AHA) has launched a nationwide data-driven research competition to uncover how inflammation contributes to cardiovascular risk and how it is currently addressed in clinical practice. The initiative, called the Systemic Inflammation Data Challenge, invites data scientists, clinicians, and researchers to leverage advanced analytics and electronic medical record (EMR) data to better understand the impact of systemic inflammation on atherosclerotic cardiovascular disease.

AHA data challenge explores links between inflammation and heart disease

Are care teams doing enough to take on inflammation? The American Heart Association hopes this new research initiative can help answer that question, and many others. 

Former American College of Cardiology (ACC) president Kim Allan Williams, Sr., MD, MACC, MASNC, FAHA, FESC, chair, department of medicine, University of Louisville School of Medicine, and an ACC delegate to the American Medical Association House of Delegates, discusses how cardiology should be focusing more on earlier prevention efforts in cardiology.

The power of prevention: Cardiologist says proactive patient care can make a big difference later in life

Former ACC president Kim Allan Williams Sr., MD, thinks cardiologists should be much more proactive. Encouraging healthy eating habits now, for example, can keep patients out of the hospital later in life and reduce healthcare spending.

vitamin d supplement heart health CVD

Yes, researchers argue, vitamin D supplements help protect the heart

The ongoing debate continues. The team behind this latest analysis pointed to more than 40 years of research to make its point.

foot feet podiatry podiatrist

Doppler ultrasound offers accurate, accessible alternative for diagnosing peripheral artery disease

Experts believe the method could be easily integrated into clinical settings and improve screening for PAD.

Ultromics EchoGo Amyloidosis artificial intelligence

AI-enhanced echocardiography improves early detection of cardiac amyloidosis

The first FDA-cleared AI model of its kind was found to be an accurate screening tool for cardiac amyloidosis.

ASE shares new recommendations for evaluating LV diastolic function, HFpEF

The new guidelines detail the use of echocardiography to evaluate patients for a variety of conditions.

Thumbnail

Statin use may protect patients from subarachnoid hemorrhages

Statins appear to be the most impactful for patients diagnosed with hypertension or cerebrovascular disease.

Thumbnail

Low-intensity focused ultrasound a noninvasive treatment option for lingering COVID symptoms

New research suggests the technique can effectively break down amyloid fibrinogen microclots, which are believed to interfere with perfusion and cause inflammation.